A CLINICAL TRIAL COMPARING GEMCITABINE AND CARBOPLATIN WITH AND WITHOUT P276-00 IN SUBJECTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER, WITH A RUN-IN OF ESCALATING DOSE OF P276-00 ADDED TO GEMCITABINE AND CARBOPLATIN: